Anti-excitotoxic sustained release intraocular implants and related methods

Details for Australian Patent Application No. 2010224394 (hide)

Owner Allergan, Inc.

Inventors Sugimoto, Hiroshi; Chang, James N.; Spada, Lon T.; Hughes, Patrick M.; Blanda, Wendy M.

Agent Davies Collison Cave

Pub. Number AU-A-2010224394

Parent 2005240081

Filing date 23 September 2010

Wipo publication date 14 October 2010

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

14 October 2010 Application Open to Public Inspection

  Published as AU-A-2010224394

14 October 2010 Complete Application Filed

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010224395-Apparatus and method for accurate detection of locomotive fuel injection pump solenoid closure

2010224393-Tampon formed from a selectively needled nonwoven fabric web